(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors
申请人:Altana Pharma AG
公开号:US06818651B2
公开(公告)日:2004-11-16
3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.
(DIHYDRO)ISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
申请人:Byk Gulden Lomberg Chemische Fabrik GmbH
公开号:EP1337515A1
公开(公告)日:2003-08-27
US6818651B2
申请人:——
公开号:US6818651B2
公开(公告)日:2004-11-16
[EN] (DIHYDRO)ISOQUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS<br/>[FR] DERIVES DE (DIHYDRO)ISOQUINOLINE COMME INHIBITEURS DE PHOSPHODIESTERASE
申请人:BYK GULDEN LOMBERG CHEM FAB
公开号:WO2002040450A1
公开(公告)日:2002-05-23
3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.
(Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors
申请人:——
公开号:US20040044212A1
公开(公告)日:2004-03-04
3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.